Filing Details
- Accession Number:
- 0001209191-12-059660
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-28 16:07:55
- Reporting Period:
- 2012-12-26
- Filing Date:
- 2012-12-28
- Accepted Time:
- 2012-12-28 16:07:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509420 | D Chandra Lovejoy | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Vp Of Regulatory Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-12-26 | 107 | $2.54 | 107 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-26 | 107 | $9.05 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2012-12-26 | 2,102 | $2.54 | 2,102 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-12-26 | 2,102 | $9.05 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2012-12-26 | 107 | $0.00 | 107 | $2.54 |
| Common Stock | Stock Option (right to buy) | Disposition | 2012-12-26 | 2,102 | $0.00 | 2,102 | $2.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 322 | 2019-03-05 | No | 4 | M | Direct | |
| 1,207 | 2019-08-13 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to a written plan as specified in Rule 10b5-1 of the Securities Exchange Act of 1934.
- Shares subject to vest monthly over a period of 48 months beginning on March 31, 2009.
- Shares subject to vest monthly over a period of 48 months beginning on August 31, 2009.
Billionaire Hedge Funds
